Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.
|
Jun 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Prognostic models in myelodysplastic syndromes
|
Jun 2015
|
Lancet Haematol
|
myelodysplastic syndromes (MDS)
|
Prognostic models in myelodysplastic syndromes
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure
|
Mar 2017
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
|
Sep 2016
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Prognostic relevance of cytogenetic systems in myelodysplastic syndromes.
|
Mar 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients
|
Mar 2017
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
Prognostic role of immunohistochemical analysis of 5mc in Myelodysplastic Syndromes.
|
May 2013
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)
|
Jul 2020
|
Leukemia
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis
|
Feb 2017
|
PLoS One
|
myelodysplastic syndromes (MDS)
|